Companion Animal Cancer Treatment Technology
Cancer treatments can cause serious side effects because drugs are often delivered throughout the entire body, not just to the tumor. This technology is creating a smarter, more targeted way to deliver cancer drugs to companion animals.
The Problem
Cancer treatments can cause serious side effects because drugs are often delivered throughout the entire body, not just to the tumor. This reduces the treatment's effectiveness and increases the risk of harm. Current methods also depend on specific cell receptors, which can vary between patients. There is a need for a drug delivery method that naturally finds and accumulates in tumors without damaging healthy tissues.
The Solution
This technology is creating a smarter, more targeted way to deliver cancer drugs. It uses a natural protein in the body called albumin to carry a powerful cancer-fighting compound directly to tumors. This helps the medicine stay in the body longer, reduces side effects, and doesn’t depend on one specific type of cancer cell to work. In preclinical testing, the treatment showed strong results against several aggressive types of lymphoma and worked as well or better than a commonly used drug called Rituximab. Researchers are also exploring how this same approach could help treat cancer in pets and are currently testing it in dogs with bone cancer. These promising results suggest this drug could lead to better, safer treatments for both people and animals.
The Opportunity
Startups and research consortia will benefit from this innovation as a springboard for developing next-generation health solutions.
